UroGen Pharma Ltd. (URGN) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
UroGen Pharma Ltd. (URGN) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$61.92 MLiabilities$384.99 MNon-current liabilities$323.07 MCurrent assets$235.43 MAssets$252.59 MNon-current assets$17.16 MEquity−$132.40 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netCash and cash equivalentsMarketable securitiesInventoriesPrepaid expenses and other current assetsRestricted cashOther non-current assetsFinance lease right-of-use assetsOperating lease right-of-use assetsProperty and equipment, netRestricted depositAccounts payable and accrued expensesEmployee related accrued expensesOther current liabilitiesCurrent liabilities related to finance leasesCurrent liabilities related to operating leasesLong-term debtPrepaid forward obligationUncertain tax positions liabilityFinance long-term lease liabilitiesOperating long-term lease liabilitiesAdditional paid-in capitalOrdinary shares, NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2026 and December 31, 2025; 48,869,530 and 48,350,272 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectivelyAccumulated deficitAccumulated other comprehensive incomeCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityAccounts payable and accrued expensesAccounts payable and accrued expenses$39.95 MCurrent liabilitiesCurrent liabilities$61.92 MEmployee related accrued expensesEmployee related accrued expenses$12.25 MOther current liabilitiesOther current liabilities$7.62 MLiabilitiesLiabilities$384.99 MCurrent liabilities related to finance leasesCurrent liabilities related to finance leases$1.41 MCurrent liabilities related to operating leasesCurrent liabilities related to operating leases$684.00 KNon-current liabilitiesNon-current liabilities$323.07 MLong-term debtLong-term debt$188.73 MPrepaid forward obligationPrepaid forward obligation$125.14 MUncertain tax positions liabilityUncertain tax positions liability$3.90 MFinance long-term lease liabilitiesFinance long-term lease liabilities$2.94 MOperating long-term lease liabilitiesOperating long-term lease liabilities$2.36 MCurrent assetsCurrent assets$235.43 MAccounts receivable, netAccounts receivable, net$88.76 MAdditional paid-in capitalAdditional paid-in capital$865.11 MAssetsAssets$252.59 MCash and cash equivalentsCash and cash equivalents$79.13 MMarketable securitiesMarketable securities$28.84 MInventoriesInventories$24.59 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$12.78 MRestricted cashRestricted cash$1.33 MOther non-current assetsOther non-current assets$8.76 MFinance lease right-of-use assetsFinance lease right-of-use assets$4.82 MNon-current assetsNon-current assets$17.16 MOperating lease right-of-use assetsOperating lease right-of-use assets$2.81 MProperty and equipment, netProperty and equipment, net$597.00 KEquityEquity−$132.40 MOrdinary shares, NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2026 and December 31, 2025; 48,869,530 and 48,350,272 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectivelyOrdinary shares$135.00 KRestricted depositRestricted deposit$178.00 KAccumulated deficitAccumulated deficit−$997.64 MAccumulated other comprehensive incomeAccumulated other comprehensive income−$2.00 K
Chart details

UroGen Pharma Ltd. (URGN) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
252,590,000 US dollars
Current assets
235,426,000 US dollars
Non-current assets
17,164,000 US dollars
Liabilities
384,986,000 US dollars
Current liabilities
61,915,000 US dollars
Non-current liabilities
323,071,000 US dollars
Equity
negative 132,396,000 US dollars
Accounts receivable, net
88,757,000 US dollars
Cash and cash equivalents
79,133,000 US dollars
Marketable securities
28,842,000 US dollars
Inventories
24,589,000 US dollars
Prepaid expenses and other current assets
12,776,000 US dollars
Restricted cash
1,329,000 US dollars
Other non-current assets
8,761,000 US dollars
Finance lease right-of-use assets
4,818,000 US dollars
Operating lease right-of-use assets
2,810,000 US dollars
Property and equipment, net
597,000 US dollars
Restricted deposit
178,000 US dollars
Accounts payable and accrued expenses
39,945,000 US dollars
Employee related accrued expenses
12,253,000 US dollars
Other current liabilities
7,622,000 US dollars
Current liabilities related to finance leases
1,411,000 US dollars
Current liabilities related to operating leases
684,000 US dollars
Long-term debt
188,734,000 US dollars
Prepaid forward obligation
125,135,000 US dollars
Uncertain tax positions liability
3,903,000 US dollars
Finance long-term lease liabilities
2,939,000 US dollars
Operating long-term lease liabilities
2,360,000 US dollars
Additional paid-in capital
865,112,000 US dollars
Ordinary shares, NIS 0.01 par value, 100,000,000 shares authorized at June 30, 2026 and December 31, 2025; 48,869,530 and 48,350,272 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
135,000 US dollars
Accumulated deficit
negative 997,641,000 US dollars
Accumulated other comprehensive income
negative 2,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
UroGen Pharma Ltd. (URGN) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!